FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns the method of chromatographic purification of tissue plasminogen activator, where zinc-chelate chromatography is performed on a metal chelate sorbent with a methacrylate matrix, then the affinity chromatography on the Capture Select tPA peptide affinity sorbent and then the tissue plasminogen activator is transferred to the final buffer solution by chromatography on a strong cation-exchange sorbent, with an increase in the content of sodium chloride and arginine in the washing buffer solutions. Invention ensures obtaining recombinant TAP with a low protein content of the producer strain, as well as expanding the arsenal of methods for purifying TAP with the obtaining of a drug suitable for medical use.
EFFECT: obtaining a drug suitable for medical use.
7 cl, 1 dwg, 3 ex, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF INDUSTRIAL PURIFICATION OF ROMIPLOSTIM | 2021 |
|
RU2804622C2 |
RECOMBINANT PLASMID DNA pMSIN4, CODING HYBRIDE POLYPEPTIDE - HUMAN INSULIN PRECURSOR, BL21(DE3)VpMSIN4-PRODUCER STRAIN OF RECOMBINANT HUMAN INSULIN, METHOD FOR PRODUCING RECOMBINANT HUMAN INSULIN | 2011 |
|
RU2447149C1 |
METHOD OF EXTRACTION AND PURIFICATION OF RECOMBINANT HUMAN PROUROKINASE M5 | 2013 |
|
RU2553533C2 |
METHOD OF PRODUCING RECOMBINANT Β-1,4-GALACTOSIDASE BGAA FROM STREPTOCOCCUS PNEUMONIAE | 2019 |
|
RU2698460C1 |
PLASMID FOR EXPRESSION IN BACTERIA CELLS OF GENUS Escherichia OF PRECURSOR OF RECOMBINANT FRAGMENT OF HUMAN TISSUE PLASMINOGEN ACTIVATOR (TPA) (RETEPLASE), BACTERIA BELONGING TO GENUS Escherichia, - PRODUCER OF PRECURSOR OF RECOMBINANT FRAGMENT OF HUMAN TPA (RETEPLASE) OR [-1] METHIONYL - FRAGMENT OF HUMAN TPA (RETEPLASE), PRECURSOR OF RECOMBINANT FRAGMENT OF HUMAN TPA (RETEPLASE), METHOD OF PRODUCTION OF PRECURSOR OF RECOMBINANT FRAGMENT OF HUMAN TPA (RETEPLASE) | 2011 |
|
RU2495933C2 |
METHOD FOR PRODUCING A HIGHLY PURIFIED RECOMBINANT HUMAN C1-ESTERASE INHIBITOR FOR APPLICATION IN MEDICINE | 2020 |
|
RU2769201C2 |
METHOD OF RECOMBINANT HUMAN INSULIN PREPARING | 1999 |
|
RU2141531C1 |
METHOD OF PURIFYING GROWTH FACTOR PROTEIN | 2011 |
|
RU2571926C2 |
METHOD FOR PRODUCING SERRATIA MARCESCENS RECOMBINANT ENDONUCLEASE | 2021 |
|
RU2795623C2 |
RECOMBINANT PLASMID DNA pET15/N-Dest+ AND METHOD FOR THE PREPARATION, THE STRAIN OF ESCHERICHIA COLI BL21(DE3)GOLD, TRANSFORMED BY RECOMBINANT DNA pET15/N-Dest+, AND A METHOD OF ITS RECEPTION, A METHOD FOR OBTAINING RECOMBINANT BIFUNCTION ENZYME - DESTABILASE OF MEDICAL LEECH | 2015 |
|
RU2658429C2 |
Authors
Dates
2019-04-03—Published
2017-07-11—Filed